🔎 Trials Near Me

Akèy › Skleroz an milti pwogresif kwonik › Missouri › St. Louis

Etid klinik pou Skleroz an milti pwogresif kwonik nan St. Louis, MO

4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
Laj 18 a 60 · Tout sèks · Mizajou Sep 22, 2026 · NCT07067463

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Ap rekriteFaz 1/2
  • Washington University, St. Louis, St Louis
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Ap rekriteFaz 3
  • John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis, St Louis
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT04047628

Etid Skleroz an milti pwogresif kwonik nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.